Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Batefiban injection in non-ST-elevation ACS patients undergoing PCI
CTR20180276Phase 2Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of batefiban in non–ST-segment elevation acute coronary syndrome (NSTE-ACS), sponsored by Bio-Thera Solutions, Ltd.. Started Mar 2018; status: completed.
02
Drugs
batefiban
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on CTR20180276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180276.